Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner

  • Michele Fiscella
    Advanced BioScience Laboratories–Basic Research Program, Molecular Oncology Section, Molecular Virology and Carcinogenesis Laboratory, Frederick, MD 21702; Laboratory of Cell Biology and Laboratory of Molecular Pharmacology, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, 37 Convent Drive, MSC 4255, Bethesda, MD 20892-4255; and Department of Microbiology and Immunology, and Kimmel Cancer Institute, Jefferson Medical College, Thomas Jefferson University,...
  • HongLiang Zhang
    Advanced BioScience Laboratories–Basic Research Program, Molecular Oncology Section, Molecular Virology and Carcinogenesis Laboratory, Frederick, MD 21702; Laboratory of Cell Biology and Laboratory of Molecular Pharmacology, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, 37 Convent Drive, MSC 4255, Bethesda, MD 20892-4255; and Department of Microbiology and Immunology, and Kimmel Cancer Institute, Jefferson Medical College, Thomas Jefferson University,...
  • Saijun Fan
    Advanced BioScience Laboratories–Basic Research Program, Molecular Oncology Section, Molecular Virology and Carcinogenesis Laboratory, Frederick, MD 21702; Laboratory of Cell Biology and Laboratory of Molecular Pharmacology, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, 37 Convent Drive, MSC 4255, Bethesda, MD 20892-4255; and Department of Microbiology and Immunology, and Kimmel Cancer Institute, Jefferson Medical College, Thomas Jefferson University,...
  • Kazuyasu Sakaguchi
    Advanced BioScience Laboratories–Basic Research Program, Molecular Oncology Section, Molecular Virology and Carcinogenesis Laboratory, Frederick, MD 21702; Laboratory of Cell Biology and Laboratory of Molecular Pharmacology, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, 37 Convent Drive, MSC 4255, Bethesda, MD 20892-4255; and Department of Microbiology and Immunology, and Kimmel Cancer Institute, Jefferson Medical College, Thomas Jefferson University,...
  • Songfa Shen
    Advanced BioScience Laboratories–Basic Research Program, Molecular Oncology Section, Molecular Virology and Carcinogenesis Laboratory, Frederick, MD 21702; Laboratory of Cell Biology and Laboratory of Molecular Pharmacology, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, 37 Convent Drive, MSC 4255, Bethesda, MD 20892-4255; and Department of Microbiology and Immunology, and Kimmel Cancer Institute, Jefferson Medical College, Thomas Jefferson University,...
  • W. Edward Mercer
    Advanced BioScience Laboratories–Basic Research Program, Molecular Oncology Section, Molecular Virology and Carcinogenesis Laboratory, Frederick, MD 21702; Laboratory of Cell Biology and Laboratory of Molecular Pharmacology, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, 37 Convent Drive, MSC 4255, Bethesda, MD 20892-4255; and Department of Microbiology and Immunology, and Kimmel Cancer Institute, Jefferson Medical College, Thomas Jefferson University,...
  • George F. Vande Woude
    Advanced BioScience Laboratories–Basic Research Program, Molecular Oncology Section, Molecular Virology and Carcinogenesis Laboratory, Frederick, MD 21702; Laboratory of Cell Biology and Laboratory of Molecular Pharmacology, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, 37 Convent Drive, MSC 4255, Bethesda, MD 20892-4255; and Department of Microbiology and Immunology, and Kimmel Cancer Institute, Jefferson Medical College, Thomas Jefferson University,...
  • Patrick M. O’Connor
    Advanced BioScience Laboratories–Basic Research Program, Molecular Oncology Section, Molecular Virology and Carcinogenesis Laboratory, Frederick, MD 21702; Laboratory of Cell Biology and Laboratory of Molecular Pharmacology, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, 37 Convent Drive, MSC 4255, Bethesda, MD 20892-4255; and Department of Microbiology and Immunology, and Kimmel Cancer Institute, Jefferson Medical College, Thomas Jefferson University,...
  • Ettore Appella
    Advanced BioScience Laboratories–Basic Research Program, Molecular Oncology Section, Molecular Virology and Carcinogenesis Laboratory, Frederick, MD 21702; Laboratory of Cell Biology and Laboratory of Molecular Pharmacology, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, 37 Convent Drive, MSC 4255, Bethesda, MD 20892-4255; and Department of Microbiology and Immunology, and Kimmel Cancer Institute, Jefferson Medical College, Thomas Jefferson University,...

抄録

<jats:p> Exposure of mammalian cells to ionizing radiation (IR) induces a complex array of cellular responses including cell cycle arrest and/or apoptosis. IR-induced G <jats:sub>1</jats:sub> arrest has been shown to depend on the presence of the tumor suppressor p53, which acts as a transcriptional activator of several genes. p53 also plays a role in the induction of apoptosis in response to DNA damage, and this pathway can be activated by both transcription-dependent and -independent mechanisms. Here we report the identification of a novel transcript whose expression is induced in response to IR in a p53-dependent manner, and that shows homology to the type 2C protein phosphatases. We have named this novel gene, <jats:italic>wip1. In vitro</jats:italic> , recombinant Wip1 displayed characteristics of a type 2C phosphatase, including Mg <jats:sup>2+</jats:sup> dependence and relative insensitivity to okadaic acid. Studies performed in several cell lines revealed that <jats:italic>wip1</jats:italic> accumulation following IR correlates with the presence of wild-type p53. The accumulation of <jats:italic>wip1</jats:italic> mRNA following IR was rapid and transient, and the protein was localized to the nucleus. Similar to <jats:italic>waf1,</jats:italic> ectopic expression of <jats:italic>wip1</jats:italic> in human cells suppressed colony formation. These results suggest that Wip1 might contribute to growth inhibitory pathways activated in response to DNA damage in a p53-dependent manner. </jats:p>

収録刊行物

被引用文献 (35)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ